Event detection using population-based health care databases in randomized clinical trials: A novel research tool in interventional cardiology

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 357-361

  Thuesen, Leif ^a   Jensen, Lisette Okkels ^b   Henrik Tilsted, Hans ^c   Mæng, Michael ^a   Terkelsen, Christian ^a   Thayssen, Per ^b   Ravkilde, Jan ^c   Christiansen, Evald Høj ^a   Erik Bøtker, Hans ^a   Madsen, Morten ^a   Lassen, Jens F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Clinical study; Coronary stents; Event detection; National registries; Pci

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; DATA BASE; DIAGNOSTIC TEST; HEALTH CARE PLANNING; HUMAN; INTERVENTION STUDY; INTERVENTIONAL CARDIOLOGY; METHODOLOGY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECALL BIAS; REGISTER;

EID: 84884401830     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S44651     Document Type: Article

References (26)

1. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26(8):804-847.
2. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323-337.
3. Fletcher RH, Fletcher SW. Treatment. In: Clinical Epidemiology: The Essentials. Baltimore: Lippincott & Wilkins; 2005:125-145.
4. Sorensen HT, Lash TL, Rothman KJ. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology. 2006;44(5):1075-1082.
5. Christiansen EH, Jensen LO, Thayssen P, et al. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial. Lancet. 2013;381(9867):661-669.
6. Jensen LO, Thayssen P, Hansen HS, et al. Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV). Circulation. 2012;125(10):1246-1255.
7. Rasmussen K, Maeng M, Kaltoft A, et al. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet. 2010;375(9720):1090-1099.
8. Galloe AM, Thuesen L, Kelbaek H, et al. Comparison of paclitaxel-and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA. 2008;299(4):409-416.
9. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86-94.
10. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-2351.
11. Ruygrok PN, Melkert R, Morel MA, et al. Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators. J Am Coll Cardiol. 1999;34(5):1507-1511.
12. Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006;114(18):1955-1961.
13. Kelbaek H, Thuesen L, Helqvist S, et al. The stenting coronary arteries in non-stress/benestent disease (SCANDSTENT) trial. J Am Coll Cardiol. 2006;47(2):449-455.
14. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
15. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999;46(4):354-357.
16. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
17. Jensen LO, Maeng M, Kaltoft A, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol. 2007;50(5):463-470.
18. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2):124-130.
19. Frobert O, Lagerqvist B, Gudnason T, et al. Thrombus aspiration in ST-elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160(6):1042-1048.
20. James S, Frobert O, Lagerqvist B. Cardiovascular registries: a novel platform for randomised clinical trials. Heart. 2012;98(18): 1329-1331.
21. Kastrati A. SORT OUT V: A new episode in the DES wars. Lancet. 2013;381(9867):609-611.
22. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773-1780.
23. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315-1323.
24. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221-231.
25. Sørensen HT, Baron JA. Registries and medical databases. In: Olsen J, Saracci R, Trichopoulos D, editors. Teaching Epidemiology: A Guide for Teachers in Epidemiology, Public Health and Clinical Medicine. Oxford: Oxford University Press; 2009.
26. Sajadieh A, Storm HH, Hansen JF. Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial. Am J Cardiol. 1999;83(9):1419-1422, A9.